title: Epo 'cytokine-doping' of heart disease patients, will it work?
authors.forename: Erik
authors.initials: E
authors.lastname: Jørgensen
authors.forename: Lene
authors.initials: L
authors.lastname: Bindslev
authors.forename: Rasmus Sejersten
authors.initials: RS
authors.lastname: Ripa
authors.forename: Jens
authors.initials: J
authors.lastname: Kastrup
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced / Q000188:drug therapy*; D004317:Doxorubicin / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000903:Antibiotics, Antineoplastic; D004921:Erythropoietin; D004317:Doxorubicin